Molecular modes of action of cantharidin in tumor cells
- 1 March 2005
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 69 (5) , 811-818
- https://doi.org/10.1016/j.bcp.2004.12.003
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Analysis of gene expression profiles in human HL‐60 cell exposed to cantharidin using cDNA microarrayInternational Journal of Cancer, 2003
- Identifying differentially expressed genes using false discovery rate controlling proceduresBioinformatics, 2003
- Thymocytes selected for resistance to hydrogen peroxide show altered antioxidant enzyme profiles and resistance to dexamethasone-induced apoptosisCell Death & Differentiation, 2001
- Norcantharidin-Induced Post-G2/M Apoptosis Is Dependent on Wild-Type p53 GeneBiochemical and Biophysical Research Communications, 2000
- A gene expression database for the molecular pharmacology of cancerNature Genetics, 2000
- The tumor suppressor p53 modifies mutational processes in a human lymphoblastoid cell lineMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1997
- The comet assay: mechanisms and technical considerationsMutation Research/DNA Repair, 1996
- Effects of norcantharidin, a protein phosphatase type-2A inhibitor, on the growth of normal and malignant haemopoietic cellsEuropean Journal Of Cancer, 1995
- A simple technique for quantitation of low levels of DNA damage in individual cellsExperimental Cell Research, 1988
- Repair capability and the cellular age response for killing and mutation induction after UVMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1982